Search
Search for:
Search for:
Find a Pharmacy
Vertice Login
Menu
About Us
About Us
Our Brand
What We Do
Our People
Contact Us
Careers
FAQ
Workers' Comp Solutions
Workers' Comp Solutions
Pharmacy
Ancillary
Clinical Services
Claims Technology
Claims Technology
Request Demo
Data Analytics
Insights
Insights
RxInformer
Worker's Comprehensive
Clinical Minute
Intelligence
Intelligence
Industry Insights Survey
Industry Insights Survey
2025
2024
2023
2022
2021
2020
2019
Blog
Infographics
Advocacy Compliance
What's Happening
What's Happening
Events
Medmonitor
Social Hub
Customer Center
Customer Center
Pharmacy Search
Ask a Pharmacist
Claims Resources
Claims Resources
Mail Order
Patient Resources
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Tag:
diabetes
4 posts found
Medmonitor
FDA Approves Generic GLP-1 Victoza Injections for Type 2 Diabetes
Victoza® (liraglutide) injections are a GLP-1 receptor agonist, a drug class experiencing shortages due to their high demand.
Read More
Medmonitor
FDA Evaluates Report of Suicidal Thoughts with GLP-1 Receptor Agonist
While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.
Read More
Medmonitor
New Depression Product and Diabetes Generic Approvals
Exuua was approved for major depressive disorder, while two diabetes medications receive generic approvals.
Read More
Medmonitor
FDA Approves Drug That Can Delay Onset of Type 1 Diabetes
Tzield (teplizumab-mzwv) injections can delay onset by several months or years.
Read More
©
2025
Healthesystems
Workers' Comp Property and Casualty PBM
Expires 01/01/2028
info-circle
caret-right
lock
map-marker
magnifier
cross
menu
arrow-right
cross-circle